Article
VEXAS syndrome: A dermatological perspective.
The Australasian journal of dermatology - 1 Nov 2022
Nguyen Jacqueline K, Routledge David, van Der Weyden Carrie, Blombery Piers, Angel Christopher M, Johnson Daryl, Goh Michelle S, Lee Adriene
Abstract excerpt
VEXAS (Vacuoles, E1 enzyme, X-linked, autoinflammatory and somatic mutation) syndrome is a genetically defined disorder identified in 2020, describing patients with inflammatory syndromes associated with haematological dysfunction. It is a severe, treatment-resistant condition, with estimated mortality between 40% and 63%. A wide range of cutaneous manifestations have been described. Here, we report on two...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
